These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38216152)

  • 1. What can multiple causes of death tell about cardiovascular mortality during COVID-19 pandemic in the United States?
    Ukolova E; Burcin B
    J Public Health (Oxf); 2024 Feb; 46(1):97-106. PubMed ID: 38216152
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examining Disparities and Excess Cardiovascular Mortality Before and During the COVID-19 Pandemic.
    Janus SE; Makhlouf M; Chahine N; Motairek I; Al-Kindi SG
    Mayo Clin Proc; 2022 Dec; 97(12):2206-2214. PubMed ID: 36336516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premature cardiovascular disease mortality with overweight and obesity as a risk factor: estimating excess mortality in the United States during the COVID-19 pandemic.
    Adair T
    Int J Obes (Lond); 2023 Apr; 47(4):273-279. PubMed ID: 36725980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexplained mortality during the US COVID-19 pandemic: retrospective analysis of death certificate data and critical assessment of excess death calculations.
    Fairman KA; Goodlet KJ; Rucker JD; Zawadzki RS
    BMJ Open; 2021 Nov; 11(11):e050361. PubMed ID: 34785551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mortality Related to Chronic Obstructive Pulmonary Disease during the COVID-19 Pandemic: An Analysis of Multiple Causes of Death through Different Epidemic Waves in Veneto, Italy.
    Fedeli U; Barbiellini Amidei C; Marcon A; Casotto V; Grippo F; Grande E; Gaisl T; Barco S
    Int J Environ Res Public Health; 2022 Oct; 19(19):. PubMed ID: 36232144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular mortality in Brazil during the COVID-19 pandemic: a comparison between underlying and multiple causes of death.
    Brant LCC; Pinheiro PC; Passaglia LG; de Souza MFM; Malta DC; Banerjee A; Ribeiro ALP; Nascimento BR
    Public Health; 2023 Nov; 224():131-139. PubMed ID: 37776607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Longitudinal Trends in Cardiovascular Risk Factor Profiles and Complications Among Patients Hospitalized for COVID-19 Infection: Results From the American Heart Association COVID-19 Cardiovascular Disease Registry.
    Hall EJ; Ayers CR; Kolkailah AA; Rutan C; Walchok J; Williams JH; Wang TY; Rodriguez F; Bradley SM; Stevens L; Hall JL; Mallya P; Roth GA; Morrow DA; Elkind MSV; Das SR; de Lemos JA
    Circ Cardiovasc Qual Outcomes; 2023 May; 16(5):e009652. PubMed ID: 37017087
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Excess mortality associated with the COVID-19 pandemic in Latvia: a population-level analysis of all-cause and noncommunicable disease deaths in 2020.
    Gobiņa I; Avotiņš A; Kojalo U; Strēle I; Pildava S; Villeruša A; Briģis Ģ
    BMC Public Health; 2022 Jun; 22(1):1109. PubMed ID: 35659648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of cardiovascular diseases in COVID-19 related mortality in the United States.
    Vasudeva R; Challa A; Al Rifai M; Polana T; Duran B; Vindhyal M; Lewis EF
    Prog Cardiovasc Dis; 2022; 74():122-126. PubMed ID: 36279944
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The US Midlife Mortality Crisis Continues: Excess Cause-Specific Mortality During 2020.
    Glei DA
    Am J Epidemiol; 2022 Sep; 191(10):1677-1686. PubMed ID: 35333293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Young were not Spared: What Death Certificates Reveal about Non-Covid Excess Deaths.
    Mulligan CB; Arnott RD
    Inquiry; 2022; 59():469580221139016. PubMed ID: 36523146
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disease-Specific Excess Mortality During the COVID-19 Pandemic: An Analysis of Weekly US Death Data for 2020.
    Zhu D; Ozaki A; Virani SS
    Am J Public Health; 2021 Aug; 111(8):1518-1522. PubMed ID: 34185569
    [No Abstract]   [Full Text] [Related]  

  • 13. How Did the Two Years of the COVID-19 Pandemic Affect the Outcomes of the Patients with Inflammatory Rheumatic Diseases in Lithuania?
    Dadonienė J; Jasionytė G; Mironova J; Staškuvienė K; Miltinienė D
    Medicina (Kaunas); 2023 Feb; 59(2):. PubMed ID: 36837512
    [No Abstract]   [Full Text] [Related]  

  • 14. Socio-demographic inequalities and excess non-COVID-19 mortality during the COVID-19 pandemic: a data-driven analysis of 1 069 174 death certificates in Mexico.
    Antonio-Villa NE; Bello-Chavolla OY; Fermín-Martínez CA; Aburto JM; Fernández-Chirino L; Ramírez-García D; Pisanty-Alatorre J; González-Díaz A; Vargas-Vázquez A; Barquera S; Gutiérrez-Robledo LM; Seiglie JA
    Int J Epidemiol; 2022 Dec; 51(6):1711-1721. PubMed ID: 36174226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of the effect of the COVID-19 pandemic on the all-cause, cause-specific mortality, YLL, and life expectancy in the first 2 years in an Iranian population-an ecological study.
    Pirayesh Z; Riahi SM; Bidokhti A; Kazemi T
    Front Public Health; 2023; 11():1259202. PubMed ID: 37927873
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estimating Overall and Cause-Specific Excess Mortality during the COVID-19 Pandemic: Methodological Approaches Compared.
    Barbiellini Amidei C; Fedeli U; Gennaro N; Cestari L; Schievano E; Zorzi M; Girardi P; Casotto V
    Int J Environ Res Public Health; 2023 May; 20(11):. PubMed ID: 37297545
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Veneto Region dementia-related mortality during the COVID-19 pandemic: multiple causes of death and time series analysis.
    Basso C; Barbiellini Amidei C; Casotto V; Schievano E; Dotto M; Tiozzo Netti S; Zorzi M; Fedeli U
    Eur J Public Health; 2023 Apr; 33(2):190-195. PubMed ID: 36847686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cause-Specific Excess Mortality During the COVID-19 Pandemic (2020-2021) in 12 Countries of the C-MOR Consortium.
    Beeks VV; Achilleos S; Quattrocchi A; Pallari CT; Critselis E; Salameh P; Rahmanian Haghighi MR; Rodriguez-Llanes JM; Ambrosio G; Artemiou A; Gabel J; Bennett CM; Cuthbertson J; Zimmermann C; Schernhammer ES; Costa AJL; de Carvalho LF; Lobato JCP; Athanasiadou M; Critchley JA; Goldsmith LP; Kandelaki L; Glushkova N; Davletov K; Semenova Y; Erzen I; Verstiuk O; Alekkou D; Polemitis A; Charalambous A; Demetriou CA;
    J Epidemiol Glob Health; 2024 Jun; 14(2):337-348. PubMed ID: 38775902
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Has the first year of the COVID-19 pandemic reversed the trends in CV mortality between 1999 and 2019 in the United States?
    Kobo O; Abramov D; Fudim M; Sharma G; Bang V; Deshpande A; Wadhera RK; Mamas MA
    Eur Heart J Qual Care Clin Outcomes; 2023 Jun; 9(4):367-376. PubMed ID: 36442154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal variation of excess deaths from diabetes during the COVID-19 pandemic in the United States.
    Yao XI; Han L; Sun Y; He D; Zhao S; Ran J
    J Infect Public Health; 2023 Apr; 16(4):483-489. PubMed ID: 36801628
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.